References
- J. Exp. Med. v.165 Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins Klickstein, L.B.;W.W. Wong;J.A. Smith;J.H. Weis;J.G. Wilson;D.T. Fearon https://doi.org/10.1084/jem.165.4.1095
- J. Exp. Med. v.168 Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis Klickstein, L.B.;Bartow, T.J.;V. Miletic;L.D. Rabson;J.A. Smith;D.T. Fearon https://doi.org/10.1084/jem.168.5.1699
- J. Exp. Med. v.168 Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1 Hourcade, D.;D.R. Miesner;J.P. Atkinson;V.M. Holers https://doi.org/10.1084/jem.168.4.1255
- Science v.249 Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflam-mation and necrosis Weisman, H.F.;T. Bartow;M.K. Leppo;H.C. Jr. Marsh;G.R. Carson;M.F. Concino;M.P. Boyle;K.H. Roux;M.L. Weisfeldt;D.T. Fearon https://doi.org/10.1126/science.2371562
- J. Immunol. v.146 Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats Yeh, C.G.;H.C. Jr. Marsh;G.R. Carson;L. Berman;M.F. Concino;S.M. Scesney;R.E. Kuestner;R. Skibbens;K.A. Donahue;S.H. Ip
- J. Immunol. v.148 Protective effects of soluble CR1 in complement and neutrophil-mediated tissue injury Mulligan, M.S.;C.G. Yeh;A.R. Rudolph;P.A. Ward
- Transplantation v.57 The effect of soluble complement receptor type 1 on hyper-acute rejection of porcine xenografts Pruitt, S.K.;A.D. Kirk;R.R. Bollinger;H.C. Jr. Marsh;B.H. Collins;J.L. Levin;J.R. Mault;J.S. Heinle;S. Ibrahim;A.R. Rudolph https://doi.org/10.1097/00007890-199402150-00009
- Neurosci. Lett. v.200 Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats Jung, S.;K.V. Toyka;H.P. Hartung https://doi.org/10.1016/0304-3940(95)12115-K
- J. Neuroimmunol. v.71 Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis Piddlesden, S.J.;S. Jiang;J.L. Levin;A. Vincent;B.P. Morgan https://doi.org/10.1016/S0165-5728(96)00144-0
- Transpl. Immunol. v.6 Prevention of hyperacute rejection by phosphatidylinositol- anchored mini-complement receptor type 1 Mikata, S.;S. Miyagawa;M. Yoshitatsu;M. Ikawa;M. Okabe;H. Matsuda;R. Shirakura https://doi.org/10.1016/S0966-3274(98)80025-7
- Eur. J. Immunol. v.26 A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway Scesney, S.M.;S.C. Makrides;M.L. Gosselin;P.J. Ford;B.M. Andrews;E.G. Hayman;H.C. Jr. Marsh https://doi.org/10.1002/eji.1830260810
- J. Biol. Chem. v.274 Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules Rittershaus, C.W.;L.J. Thomas;D.P. Miller;M.D. Picard;K.M. Geoghegan-Barek;S.M. Scesney;L.D. Henry;A.C. Sen;A.M. Bertino;G. Hannig;H. Adari;R.A. Mealey;M.L. Gosselin;M. Couto;E.G. Hayman;J.L. Levin;V.N. Reinhold;H.C. Jr. Marsh https://doi.org/10.1074/jbc.274.16.11237
- J. Immunol. v.146 Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function Wong, W.W.;S.A. Farrell
- J. Biochem. Biophys. Methods. v.32 Rapid purification of human complement receptor type 1 (CD35, CR1) Seya, T.;M. Matsumoto;M. Hatanaka, M.;Okada, T.;Masaki;K. Iida https://doi.org/10.1016/0165-022X(95)00005-C
- Nature v.227 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Laemmli, U.K. https://doi.org/10.1038/227680a0
- J. Immunol. v.134 Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele Dykman, T.R.;J.A. Hatch;M.S. Aqua;J.P. Atkinson
- Biochim. Biophys. Acta v.1289 Factor H co-purifies with thrombospondin isolated from platelet secretate Carron, J.A.;R.C. Bates;A.I. Smith;T. Tetoz;A. Arellano;D.L. Gordon;G.F. Burns https://doi.org/10.1016/0304-4165(95)00095-X
- J. Biosci. Bioeng. v.89 Direct refolding of recombinant human growth differntiation factor 5 for large-scale production process Honda, J.;H. Andou;T. Mannen;S. Sugimoto https://doi.org/10.1016/S1389-1723(00)80061-4
- J. Immunol. v.153 Primary sequence of an alternatively spliced form of CR1. Candidate for the 75.000 M(r) complement receptor expressed on chimpanzee erythrocytes Birmingham, D.J.;X.P. Shen;D. Hourcade;M.W. Nickells;J.P. Atkinson
- Clin. Exp. Immunol. v.112 Mapping epitopes for 20 monoclonal antibodies to CR1 Nickells, M.;R. Hauhart;M. Krych;V.B. Subramanian;K. Geoghegan-Barek;H.C. Jr. Marsh;J.P. Atkinson https://doi.org/10.1046/j.1365-2249.1998.00549.x
- J. Immunol. v.144 Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3" Hack, C.E.;J. Paardekooper;F. Van Milligen
- Mol. Immunol. v.28 Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors Seya, T.;M. Okada;K. Hazeki;S. Nagasawa https://doi.org/10.1016/0161-5890(91)90150-I
- J. Exp. Med. v.188 Complement dependent clearance of apoptotic cells by human macrophages Mevorach, D.;J.O. Mascarenhas;D. Gershov;K.B. Elkon https://doi.org/10.1084/jem.188.12.2313
- Xenoiransplantation v.8 Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition Carrington, C.A.;G. dos Santos Cruz https://doi.org/10.1034/j.1399-3089.2001.00086.x
- FEMS Immunol. Med. Microbiol. v.31 Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP Huang, J.;D. Gou;C. Zhen;D. Jiang;X. Mao;W. Li;S. Chen;C. Cai https://doi.org/10.1111/j.1574-695X.2001.tb00521.x
- Hum. Cell. v.4 Cultivation of mammalian cells in serum-free media Umeda, M.
- Vitro Cell Dev. Biol. Anim. v.37 Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT Fukaya, K.;S. Asahi;S. Nagamori;M. Sakaguchi;C. Gao;M. Miyazaki;M. Namba https://doi.org/10.1007/BF02577541
- Vitro Cell Dev. Biol. Anim. v.33 Heparan sulfate is required for interaction and activation of the epithelial cell fibroblast growth factor receptor-2Ⅲb with stromal-derived fibroblast growth factor-7 Jang, J.H.;F. Wang;M. Kan https://doi.org/10.1007/s11626-997-0162-7
- Blood v.98 Purification of human von Willebrand factorcleaving protease and its identification as a new member of the metalloproteinase family Fujikawa, K.;H. Suzuki;B. McMullen;D. Chung https://doi.org/10.1182/blood.V98.6.1662
- J. Clin. Invest. v.99 Heparan Sulfate Proteoglycans of the Cardiovascular System Rosenberg, R.D.;N.W. Shworak;J. Liu;L. Zhang https://doi.org/10.1172/JCI119377
- J. Hepatol. v.30 Active form of human hepatocyte growth factor is excreted into bile after hepatobiliary resection Kurumiya, Y.;Y. Nimura;E. Takeuchi;K. Nozawa;M. Nagino;A. Hayata;A. Maeda;S. Yoshida https://doi.org/10.1016/S0168-8278(99)80004-X
- J. Chromatogr. B. Biomed. Sci. Appl. v.737 Preparative two-step purification of recombinant human basic fibroblast growth factor from high-cell-density cultivation of Escherichia coli Garke, G.;W.D. Deckwer;F.B. Anspach https://doi.org/10.1016/S0378-4347(99)00394-1
- Biotechnol. Appl. Biochem. v.33 Improved preparation and crystallization of 25 kDa human fibroblast growth factor-9 Koyama, N.;H. Ohmae;S. Tsuji;Y. Tanaka;T. Kurokawa;O. Nishimura https://doi.org/10.1042/BA20000075
- J. Immunol. v.135 Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor(DAF) Seya, T.;V.M. Holers;J.P. Atkinson
- Ann. Thorac. Surg. v.63 Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass Moen, O.;K. Hogasen;E. Fosse;E. Dregelid;V. Brockmeier;P. Venge;M. Harboe;T.E. Mollnes https://doi.org/10.1016/S0003-4975(96)00743-6
- Artif. Organs v.24 Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass Saito, N.;S. Motoyama;J. Sawamoto https://doi.org/10.1046/j.1525-1594.2000.06520.x
- J. Immunol. v.126 Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase Skerl, K.G.;R.A. Calderone;T. Sreevalsan;J. Burge;A. Nicholson-Weller;K.F. Austen
- J. Immunol. v.126 Murine C4-binding protein: a rapid purification method by affinity chromatography Kaidoh, T.;S. Natsuume-Sakai;M. Takahashi
- Int. Immunopharmacol v.1 C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae Ram, S.;M. Cullinane;A.M. Blom;S. Gulati;D.P.;McQuillen;R. Boden;B.G. Monks;C.O. Connell;C. Elkins;M.K. Pangburn;B. Dahlback;P.A. Rice https://doi.org/10.1016/S1567-5769(00)00037-0
- Biochim. Biophys. Acta v.1289 Factor H co-purifies with thrombospondin isolated from platelet secretate Carron, J.A.;R.C. Bates;A.I. Smith;T. Tetoz;A. Arellano;D.L. Gordon;G.F. Burns https://doi.org/10.1016/0304-4165(95)00095-X
- J. Immunol. Methods v.202 Effects of thrombospondin purified by heparin affinity or ion-exchange chromatography on the alternative complement pathway Scott, P.E.;D.B. Purkall;S. Ruddy https://doi.org/10.1016/S0022-1759(97)00006-9
- J. Pharmacol. Exp. Ther. v.281 Activation of the alternative pathway of complement by a phos-phorothioate oligonucleotide: potential mechanism of action Henry, S.P.;P.C. Giclas;J. Leeds;M. Pangburn;C. Auletta;A.A. Levin;D.J. Kornbrust
- J. Biol. Chem. v.264 Factor J: Isolation and characterization of a new polypeptide inhibitor of complement C1 Lopez-Trascasa, M.;D.H. Bing;M. Rivard;A. Nicholson-Weller
- J. Cell Biol. v.130 Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1) Diamond, M.S.;R. Alon;C.A. Parkos;M.T. Quinn;T.A. Springer https://doi.org/10.1083/jcb.130.6.1473
- Circulation v.100 Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18) Peter, K.;M. Schwarz;C. Conradt;T. Nordt;M. Moser;W. Kubler;C. Bode https://doi.org/10.1161/01.CIR.100.14.1533
- Artif. Organs v.16 C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations Sinitsyn, V.V.;E.T. Bokchubaev;A.G. Mamontova;N.V. Ovtrakht;E.L. Nasonov;G.A. Konovalov;V.V. Kukharchuk https://doi.org/10.1111/j.1525-1594.1992.tb00312.x
- Blood v.96 Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury Lidington, E.A.;D.O. Haskard;J.C. Mason